Polysciences — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Polysciences is a long-established, privately-held specialty chemical manufacturer and service provider supporting advanced research and industrial applications. Its core business model is service-oriented, providing custom synthesis and contract manufacturing, with a strategic focus on the high-growth cell and gene therapy market through its Kyfora Bio brand. With all manufacturing located in the United States, the company positions itself as a reliable, onshore supplier to minimize tariff and logistical disruptions for its clients. Its diversified portfolio across life sciences, electronics, and materials science provides a stable revenue base while targeting emerging biotech opportunities.

DiagnosticsAntibodiesCell Therapy

Technology Platform

Integrated capabilities in polymer science, organic synthesis, and particle engineering for custom chemical and material manufacturing.

Opportunities

Significant growth is driven by the expanding cell and gene therapy market, where its Kyfora Bio brand supplies critical bioprocessing reagents.

Its exclusive US manufacturing base is a major advantage for clients seeking to de-risk supply chains and avoid tariffs, aligning with trends toward reshoring.

Risk Factors

Key risks include exposure to raw material cost volatility, intense competition from larger global chemical and life science suppliers, and the cyclical nature of some end-markets like electronics.

Maintaining stringent regulatory compliance for life science materials is also an ongoing challenge.

Competitive Landscape

Polysciences competes with large, diversified life science suppliers like Thermo Fisher Scientific and Merck KGaA (MilliporeSigma), as well as specialized contract development and manufacturing organizations (CDMOs) and chemical companies. Its differentiation lies in its deep expertise in polymers and particles, flexible custom synthesis services, and its strategically located US manufacturing footprint.

More companies in Drug Delivery & Formulation →More companies in United States →